Caroline A Cuoco

Affiliations: 
NIH, NINDS 
Area:
Dopamine Receptor Pharmacology
Google:
"Caroline Cuoco"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
David R. Sibley research scientist 2017-2019 NIH
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Free RB, Cuoco CA, Xie B, et al. (2021) Pharmacological characterization of the imipridone anti-cancer drug ONC201 reveals a negative allosteric mechanism of action at the D dopamine receptor. Molecular Pharmacology
Prabhu VV, Morrow S, Cuoco CA, et al. (2020) Abstract 5688: IND-enabling characterization of ONC206 as the next bitopic antagonist for oncology Cancer Research. 80: 5688-5688
Prabhu V, Cuoco C, Jung J, et al. (2020) DDRE-33. MOLECULAR DIFFERENTIATION OF IMIPRIDONES ONC201 AND ONC206 Neuro-Oncology. 22: ii68-ii68
Benjamin Free R, Cuoco C, Prabhu V, et al. (2019) EXTH-33. RECEPTOR PHARMACOLOGY OF ONC201: THE FIRST BITOPIC DRD2 ANTAGONIST FOR CLINICAL NEURO-ONCOLOGY Neuro-Oncology. 21: vi89-vi89
Prabhu V, Cuoco C, Jung J, et al. (2019) DDIS-20. IMIPRIDONE STRUCTURE ACTIVITY RELATIONSHIP UNCOVERS ONC206 AS THE NEXT BITOPIC DRD2 ANTAGONIST FOR ONCOLOGY WITH DIFFERENTIATED RECEPTOR PHARMACOLOGY Neuro-Oncology. 21: vi67-vi67
Cuoco CA, Free RB, Willette BK, et al. (2018) Characterization of the novel anti-cancer therapeutic ONC201 and related analogs as non-competitive antagonists of the D2 dopamine receptor The Faseb Journal. 32
See more...